- Adaptimmune Therapeutics (NASDAQ:ADAP) is a stock I gave you after it popped, pulled back, and decided to pop again, but it hasn’t started to follow through yet. On Thursday, it was down 20 cents, or -4.8%, to 3.97, after reaching a high of 4.17, on 555,202 shares traded Although it’s extending, the danger is that if it rolls over under 3.45-.50, I would stop it. If it gets above the 4.95 range, it could see 6, or 8, or more. We’ll have to see what happens next.
- Amkor Technology (NASDAQ:AMKR) had a big explosive move this week that I thought on a very impressive earnings report, but apparently Wall Street did not as it reversed sharply on Wednesday, and then made a further drop on Thursday, taking it down 28 cents, or -2.16%, to 12.71, on 1.5 million shares traded. Although on low volume, this is at the gap and at support, and as low as I want to see it go is about 12 1/2. I’m expecting a snapback. If it gets one, it should go back up to 13 3/4-14, then 15 and 17 3/4, which are the targets if it doesn’t breakdown and just stop.
- Anavex Life Sciences (NASDAQ:AVXL), on the other hand, broke out, got quiet for two days, and then, boom, the last two sessions have been terrific, on Thursday gaining 33 cents, or 7%, to 5.34, before pulling back and closing up 4.97, on 3 million shares traded. My targets are 6 1/2 and 8 1/4.
- Maxar Technologies (NYSE:MAXR) has a beautiful, long-term play as it started to run up again. On Thursday, it was down 14 cents, or -0.74%, to 18.85, after reaching up to 19.19, on 1.3 million shares traded, but may have started to accelerate again, four waves up and wave five may have started. Two-consecutive inside days tell me that this goes higher. I’m looking it to make a run at the old high around 21.45, and then I’m looking for 26.
- Tandem Diabetes Care (NASDAQ:TNDM) is looking very good. It has a long base, it flagged, broke out, had an inside day, and for two days in a row it was up, on Thursday, jumping 1.97, or 2.34%, to 83.02, after climbing to an afternoon session and multi-week high of 83.91, on nearly 2 million shares traded. I’m looking for it to go to 90, and then 99.
- Unisys Corporation (NYSE:UIS) popped 73 cents, or 4.3%, to new highs at 18.83, then pulled back and closed up 17.67, on 1.7 million shares traded on Thursday. I love the way this has acted the last few days. I’m looking for it to extend, first to 21 1/2, and then to the mid-20’s.
Stocks on the long side included Adaptimmune Therapeutics plc (ADAP), Amkor Technology, Inc. (AMKR), Anavex Life Sciences Corp. (AVXL), eGain Corporation (EGAN), Fulgent Genetics, Inc. (FLGT), Maxar Technologies Inc. (MAXR), NantKwest, Inc. (NK), Neoleukin Therapeutics, Inc. (NLTX), Puma Biotechnology, Inc. (PBYI), Tandem Diabetes Care, Inc. (TNDM), Unisys Corporation (UIS), and Slack Technologies, Inc. (WORK).